CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDK5R1 | Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | | | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CRMP1 | Collapsin response mediator protein 1 | | | | | | Tissue enhanced |
DOCK3 | Dedicator of cytokinesis 3 | Disease related genes
| | | | | Tissue enhanced |
FAM135B | Family with sequence similarity 135, member B | | | | | | Tissue enhanced |
FAM189A1 | Family with sequence similarity 189, member A1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPRC5B | G protein-coupled receptor, family C, group 5, member B | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
JAKMIP2 | Janus kinase and microtubule interacting protein 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | | | | | | Tissue enhanced |
NOL4 | Nucleolar protein 4 | | | | | | Tissue enhanced |
NOS1AP | Nitric oxide synthase 1 (neuronal) adaptor protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NOVA1 | Neuro-oncological ventral antigen 1 | | | | | | Tissue enhanced |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NYAP1 | Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 | | | | | | Tissue enhanced |
PHACTR3 | Phosphatase and actin regulator 3 | | | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins
| | | | | Tissue enhanced |
PPM1E | Protein phosphatase, Mg2+/Mn2+ dependent, 1E | Enzymes
| | | | | Tissue enhanced |
PSRC1 | Proline/serine-rich coiled-coil 1 | | | | | | Tissue enhanced |
RNF157 | Ring finger protein 157 | | | | | | Tissue enhanced |
RNF165 | Ring finger protein 165 | | | | | | Tissue enhanced |
RTN4R | Reticulon 4 receptor | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC25A22 | Solute carrier family 25 (mitochondrial carrier: glutamate), member 22 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLITRK5 | SLIT and NTRK-like family, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
SOX2 | SRY (sex determining region Y)-box 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
SPTBN2 | Spectrin, beta, non-erythrocytic 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
SV2C | Synaptic vesicle glycoprotein 2C | Predicted membrane proteins
| | | | | Tissue enhanced |
SYT2 | Synaptotagmin II | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TCEAL7 | Transcription elongation factor A (SII)-like 7 | | | | | | Tissue enhanced |
TREM2 | Triggering receptor expressed on myeloid cells 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
WNT7A | Wingless-type MMTV integration site family, member 7A | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ZIC1 | Zic family member 1 | Transcription factors
| | | | | Tissue enhanced |
ZNF488 | Zinc finger protein 488 | Predicted secreted proteins
| | | | | Tissue enhanced |